SciLifeLab researchers awarded this year’s Rudbeck and Linnaeus Medals

Published: 2018-12-05



Linneanum, Uppsala University. The Linnaeus Medal has been awarded since 2007, the 300th anniversary of Carl von Linné’s birth, and the Rudbeck Medal since 2003, the 300th anniversary of Olof Rudbeck’s passing. Image credit: Uppsala University.

The winners of this year’s Linnaeus and Rudbeck Medals, awarded by Uppsala University for extraordinarily outstanding research, have now been announced. The Linnaeus Medal is awarded to SciLifeLab researcher Leif Andersson, and one of the Rudbeck Medals to Per Artursson, also a SciLifeLab researcher. The medals will be presented at the Winter Conferment Ceremony on January 25 2019.

Leif Andersson, SciLifeLab researcher and Professor at the Department of Medicinal Biochemistry and Microbiology at Uppsala University, is awarded this year’s Linnaeus medal with the following motivation, presented in a press release from Uppsala University: 

“Leif Andersson, Professor of Functional Genomics, has for many years led an eminent research group studying the genetics of domestic animals. The results from his group have proven very relevant also to the emergence mechanisms of complex genetic diseases in humans. Within this field, Leif Andersson has broken new ground and his research has been rewarded with several national and international awards.”

Per Artursson, SciLifeLab researcher leading the Drug Delivery group and Professor at the Department of Pharmacy at Uppsala University, is awarded one of the Rudbeck Medals, with the motivation:

“Per Artursson is a Professor in Drug Formulation at the Department of Pharmacy. Early in his career, he was a pioneer in the development of cell models that could be used to study drug absorption from the gastrointestinal canal, using so called Caco-2 cells, methods that later have become obvious principles within the pharmaceutical industry and academic research. He has also been key in the research on transport proteins, their role in the absorption of drugs in the intestines and liver, and the interaction between them and drug-degrading enzymes.”

More information: press release from Uppsala University